image
GlycoMimetics, Inc. GLYC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.416
4.16 %
$ 26.8 M
Market Cap
-0.69
P/E
BALANCE SHEET
45.3 M ASSETS
-12.54%
Growth Rates
1Year -12.54%
3Years -31.80%
5Years -26.75%
7Years 0.96%
10Years 23.97%
6.9 M LIABILITIES
-22.28%
Growth Rates
1Year -22.28%
3Years -22.12%
5Years -5.94%
7Years -0.38%
10Years 11.25%
38.4 M EQUITY
-10.52%
Growth Rates
1Year -10.52%
3Years -33.09%
5Years -28.49%
7Years 1.21%
10Years 29.45%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition GlycoMimetics, Inc.
image
Current Assets 43.8 M
Cash & Short-Term Investments 41.8 M
Receivables 176 K
Other Current Assets 1.82 M
Non-Current Assets 1.53 M
Long-Term Investments 0
PP&E 768 K
Other Non-Current Assets 758 K
Current Liabilities 6.84 M
Accounts Payable 868 K
Short-Term Debt 742 K
Other Current Liabilities 5.23 M
Non-Current Liabilities 66.8 K
Long-Term Debt 66.8 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 41.8 47.9 90.3 137.0 158.2 209.9 123.9 40.0 46.8 55.2 2.3 17.4 28.2
Short Term Investments 0 0 0 0 0 0 0 10.6 K 9.27 K 16.3 K 1 K 0 0
Receivables 0.2 0.1 1.35 K 2.15 K 0.2 0.4 0.1 0.3 38.7 K 22.3 K 0 0 0
Inventory 0 (0.1) (533.8) (1 237.1) (4 322.2) 405 0 0.2 0.4 77 0 0 0
Other Current Assets 1.8 2.7 0.5 1.2 4.1 1.9 3.2 0.2 0.4 0.9 2.6 0.6 0.2
Total Current Assets 43.8 50.7 90.3 138.3 162.5 212.3 127.2 40.5 47.2 56.1 4.9 18.0 28.4
PP&E 0.8 1.0 1.9 2.9 3.8 1.0 1.1 1.1 0.5 0.5 0.4 0.5 0.2
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.8 0.1 2.1 1.6 1.6 1.6 0.3 0.8 0.7 0.7 0 (0.5) 0.3
Other Assets 1 411 0 169 321 272 0 327 279 27 0 0 0
Total Assets 45.3 51.8 94.3 142.8 168.0 214.8 128.6 42.4 48.5 57.3 5.3 18.4 28.9
LIABILITIES
Accounts Payable 0.9 1.0 2.1 2.1 1.4 2.7 2.6 1.6 0.6 0.9 1.1 0.8 0.5
Short Term Debt 0.7 0.9 1.0 0.9 0.8 0 0 0 0 0 0 0 0
Other Current Liabilities 5.2 7.0 8.7 9.4 8.7 6.1 5.5 4.8 7.2 5.6 1.1 0.9 0.8
Total Current Liabilities 6.8 8.9 11.8 12.4 11.0 8.8 8.2 6.3 7.7 6.5 2.3 5.7 16.4
Long Term Debt 66.8 K 0 0.9 1.9 2.8 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0.3 0 0.6 0.7 0.8 0.2 0 96.8 K 0.2 0
Total Liabilities 6.9 8.9 12.7 14.6 13.8 9.4 8.9 7.1 8.0 6.5 2.4 5.9 20.5
EQUITY
Common Stock 64.4 K 54.4 K 52.3 K 49 K 43.5 K 43.2 K 34.4 K 23.2 K 19 K 18.9 K 1.43 K 10.2 K 930
Retained Earnings (456.5) (419.6) (372.9) (309.5) (258.4) (200.6) (152.3) (119.0) (87.2) (74.4) (63.3) (52.7) (56.3)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (1.6) (1.3) (1.1) (0.9) (0.9) (0.8) (0.8) (0.7)
Total Equity 38.4 42.9 81.6 128.2 154.2 205.5 119.7 35.3 40.5 50.8 2.9 12.5 8.5
Total Liabilities and Equity 45.3 51.8 94.3 142.8 168.0 214.8 128.6 42.4 48.5 57.3 5.3 18.4 28.9
SHARES OUTSTANDING
Common Shares Outstanding 63.3 52.5 51.5 45.7 43.3 41.0 29.4 21.3 19.0 18.5 1.2 1.2 1.2